A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the critical federal funding at risk and what this ...
Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...
2d
Live Science on MSNSimple blood tests could be the future of cancer diagnosisBlood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?
Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolic ...
Scientists at the Garvan Institute of Medical Research have found that pancreatic cancer uses a key metabolic switch to help ...
The American Cancer Society’s annual cancer trends report revealed some findings that are worrying oncologists. Experts ...
The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient ...
6d
News-Medical.Net on MSNNeuropeptide Y identified as key driver of pancreatic cancer spreadResearchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...
The FDA granted an orphan drug designation to PEP-010 for the treatment of patients with metastatic pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results